America Eliminated Measles 25 Years Ago. Now, the U.S. is About to Lose One Of Its Biggest Public Health Wins

The U.S. may be close to losing its measles-free status.

The first cases looked like the kind America had learned to manage. Two infections, imported into Texas in January 2025, should have been sparks landing on wet ground. For a quarter-century, that has been the case in the United States.

This time, it stayed.

A new analysis by researchers at Boston Children’s Hospital and Harvard Medical School suggests that the United States is now in serious danger of losing one of its major public health achievements: the measles elimination status it earned in 2000.

The team applied the same kind of indicators the CDC used to judge whether measles transmission had truly been stopped. The results are stark. The country has already missed four of seven benchmarks, and the remaining three are wobbling. The decision itself will come later, when a Pan American Health Organization expert panel reviews the evidence in November 2026. But the warning signs are already there. Measles looks to be making a comeback courtesy of irresponsible vaccine hesitancy.

The Disease That Exploits Small Gaps

Measles is not merely another childhood rash. It is one of the most contagious known human viruses. It spreads through the air, can linger after an infected person leaves a room, and finds unvaccinated pockets with ruthless efficiency.

That is why “elimination” never meant eradication. The virus still circulates globally, so travelers can easily bring it into the U.S, where it spreads like wildfire if it finds non-immunized hosts. What worked until relatively recently was whether outbreaks burned out quickly.

For years, they usually did.

After the U.S. declared measles eliminated in 2000, public health agencies watched for a specific pattern: Were cases rare? Were most imported? Were outbreaks few and small? Was each infected person, on average, infecting less than one other person? Was vaccination high enough to block spread?

×

Get smarter every day...

Stay ahead with ZME Science and subscribe.

Daily Newsletter
The science you need to know, every weekday.

Weekly Newsletter
A week in science, all in one place. Sends every Sunday.
No spam, ever. Unsubscribe anytime. Review our Privacy Policy.

Thank you! One more thing...

Please check your inbox and confirm your subscription.

In 2011, the U.S. still passed that test with flying colors.

In the new analysis, it no longer does.

The researchers found that by February 17, 2026, the U.S. had reached 93.2 measles cases per 10 million people, far above the suggested benchmark of fewer than one case per 10 million. Only 6.3% of cases were imported, meaning the overwhelming majority were acquired locally. In other words, the problem was no longer just measles arriving from vulnerable places. It was measles circulating.

The outbreak that began in Texas had spread to 45 states by the time of the paper. The CDC’s current public tally, updated May 1, 2026, lists 1,803 measles cases in 2026 across 37 jurisdictions.

The Indicators Turn Red

The Boston Children’s team built its warning around seven indicators. Four have already failed.

The first is incidence. Measles should remain extremely rare in a country that has eliminated it. It has not.

The second is importation. If elimination still holds, most cases should come from abroad. Instead, more than 90% of cases in the analysis were locally transmitted.

The third is outbreak control. The benchmark calls for only a small number of outbreaks, each limited in size. The paper reports 48 outbreaks in 2025 alone, with 90% of confirmed cases linked to outbreaks.

The fourth is transmission intensity, measured by the effective reproduction number, or Rt. When Rt stays below 1, outbreaks shrink. When it rises above 1, the virus spread expands. The researchers estimated that Rt was above 1 on 285 of 376 days after January 2025 — for more than three quarters of the period studied.

Now, that does not mean measles has spread evenly everywhere. Outbreaks often grow in clusters, especially in undervaccinated communities. But for elimination status, the national pattern matters.

The paper’s conclusion is unusually direct for a brief scientific correspondence: “Given the current epidemiological context, it appears highly likely that the USA will lose its measles elimination status in 2026.”

A Public Health Achievement Is Not Self-Maintaining

The U.S. eliminated measles through vaccination. There’s no other proven measure that can achieve the same goal. The shift to a two-dose measles, mumps and rubella vaccine schedule helped close the gaps that one dose left behind. High coverage meant that when measles entered the country, it usually ran into immune people.

That protection has thinned.

Herd immunity against measles typically requires about 95% of people to have received two doses of vaccine. For the 2024–2025 school year, U.S. kindergarten MMR coverage stood at 92.5%, according to the CDC data cited in the paper. That national average also hides sharper local declines. In previous work on the Texas outbreak, the same research group estimated community-level vaccination coverage as low as 79.2% to 89.6%.

Measles only needs a classroom, a church, a sports team, a neighborhood, or a county where enough people remain susceptible.

“Declining vaccination rates have already been a warning sign that measles could return,” said Anne Bischops, a pediatrician, postdoctoral research fellow at Boston Children’s Hospital, and co-author of the study, in a press release. “However, losing status would be a clear and very concerning indicator.”

Losing elimination status would mean the U.S. can no longer credibly say it has stopped continuous measles transmission. It would place the country alongside others that have recently slipped backward. Canada lost its elimination status on November 10, 2025, and PAHO declared that the Region of the Americas had lost its measles-free status. In January 2026, six European countries, including the UK and Spain, also lost measles elimination status, according to the Lancet correspondence.

The Damage Can Come Later

One reason measles is often underestimated is that many people imagine it as a short illness that causes minor fever, cough, and rash before recovery. That’s not always so.

Measles can cause pneumonia, ear infections, brain inflammation, hospitalization, and even death. It can also weaken immune memory, making people more vulnerable to other infections after they recover. Rarely, it can lead years later to a fatal neurological disease called subacute sclerosing panencephalitis. An estimated 95,000 people died from measles in 2024 alone, with the majority being children under five years old.

“Viral infections aren’t all benign and a measles infection, even when cleared, can result in lifelong problems,” said Maimuna Majumder, Inaugural Peter Szolovits Distinguished Scholar in the Computational Health Informatics Program at Boston Children’s Hospital.

“Babies less than a year old are among those at greatest risk for severe complications, and the full impact on children exposed during the current outbreak may only show up years later.”

This is the cruel arithmetic of measles vaccination. Infants too young to be fully vaccinated depend on the immunity of others. So do some children with medical conditions. A drop in coverage changes the safety of the room for everyone in it, even the responsible ones who were vaccinated (because vaccines never offer 100% protection).

RelatedPosts

Read Roald Dahl’s powerful letter to parents about vaccination from 1988
The United States slides towards measles epidemics (again) because people don’t vaccinate
Measles cases spike globally with a 26% increase from last year
RFK Jr, Nation’s Top Health Official, Refuses to Recommend the Measles Vaccine, Says ‘I Don’t Think People Should Be Taking Medical Advice from Me’

What Happens Next

The U.S. has not officially lost measles elimination status yet. That decision will require a formal review, with more detailed evidence on where cases occurred, how outbreaks linked together, and what viral genetic sequencing shows.

But the available evidence points in one direction. The paper notes that most sequenced samples shared the same genotype, with a large share belonging to a distinctive sequence. That does not by itself prove every case came from one unbroken chain. But it raises concern that many cases are connected epidemiologically rather than representing isolated importations.

The remaining indicators are also at risk. The U.S. has not achieved a four-week stretch in which infections clearly came only from outside the country. Vaccination coverage remains below the herd immunity threshold.

The lesson of this outbreak is almost painfully simple. Measles elimination was not a permanent trophy. It was a condition the country had to keep producing — school year after school year, clinic by clinic, child by child.

The virus did not change its strategy. It was ultimately still people who weakened the wall that held it back.

The new findings were presented in The Lancet.